Author

Y. Manjunath

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 2

Signature Assays, Organisms & Methods

Click to filter · or open tag

Organism:human· 2 Assay:bulk RNA-seq· 1 Research Focus:cell type annotation· 1 Research Focus:differential expression· 1 Research Focus:drug response / drug discovery· 1 Approach:experimental assay· 1 Assay:metagenomics· 1 Assay:proteomics· 1

Frequent Co-Authors

G. Li· 2 shared A. Garcia· 1 shared A. Srivastava· 1 shared B. Dhagat· 1 shared C. Y. Chabu· 1 shared C.-R. Shyu· 1 shared F. Gao· 1 shared G. P. Vadla· 1 shared

Activity by Year

2021-2023 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 25 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersCancer Biology

G. Li

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Patient-derived tumor organoids from resected non-small cell lung cancers for high-throughput response testing with approved and repurposed drugs

K. N. Suvilesh, Y. Manjunath, Y. I. Nussbaum, M. Gadelkarim, A. Srivastava, G. Li, W. C. Warren, C.-R. Shyu, F. Gao, M. Ciorba, J. B. Mitchem, S. Rachagani, J. T. Kaifi

This study develops patient-derived tumor organoids from non-metastatic NSCLC tumors to test drug responses and identify chemoresistance mechanisms, finding 50% of organoids were chemo-resistant and could be sensitized by repurposed drugs.

bioRxiv · Oct 18, 2023 · PreprintCancer Biology

Combining Plasma Extracellular Vesicle Let-7b-5p, miR-184 and Circulating miR-22-3p Levels for NSCLC Diagnosis and Drug Resistance Prediction

G. P. Vadla, B. Dhagat, A. Garcia, G. Perez, V. Ahmad, N. Patterson, Y. Manjunath, J. Kaifi, G. Li, C. Y. Chabu

This study identifies a miRNA biomarker signature combining plasma extracellular vesicle and circulating miRNAs to improve NSCLC diagnosis and predict resistance to Osimertinib.

bioRxiv · Aug 15, 2021Cancer Biology